BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10453199)

  • 1. Clinical manifestations and treatment of Menkes disease and its variants.
    Kodama H; Murata Y; Kobayashi M
    Pediatr Int; 1999 Aug; 41(4):423-9. PubMed ID: 10453199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.
    Kodama H; Fujisawa C; Bhadhprasit W
    Curr Drug Metab; 2012 Mar; 13(3):237-50. PubMed ID: 21838703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menkes disease: recent advances and new insights into copper metabolism.
    Tümer Z; Horn N
    Ann Med; 1996 Apr; 28(2):121-9. PubMed ID: 8732640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype.
    Proud VK; Mussell HG; Kaler SG; Young DW; Percy AK
    Am J Med Genet; 1996 Oct; 65(1):44-51. PubMed ID: 8914740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.
    Tümer Z
    Hum Mutat; 2013 Mar; 34(3):417-29. PubMed ID: 23281160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inborn errors of copper metabolism.
    Kaler SG
    Handb Clin Neurol; 2013; 113():1745-54. PubMed ID: 23622398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and pathophysiology of Menkes disease.
    Kodama H; Murata Y
    Pediatr Int; 1999 Aug; 41(4):430-5. PubMed ID: 10453200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menkes' syndrome: an updated review.
    Hart DB
    J Am Acad Dermatol; 1983 Jul; 9(1):145-52. PubMed ID: 6886097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and molecular bases of Menkes disease and occipital horn syndrome.
    Kaler SG
    Pediatr Dev Pathol; 1998; 1(1):85-98. PubMed ID: 10463276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Menkes' disease: heterozygosity testing by quantitative real-time PCR and the dilemma of therapeutic support].
    Rittinger O; Sander G; Schaller A; Gallati S; Mayr H; Sperl W
    Klin Padiatr; 2005; 217(5):286-90. PubMed ID: 16167277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Copper metabolism and genetic disorders].
    Shimizu N
    Nihon Rinsho; 2016 Jul; 74(7):1151-5. PubMed ID: 27455805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology, clinical features and treatments of congenital copper metabolic disorders--focus on neurologic aspects.
    Kodama H; Fujisawa C; Bhadhprasit W
    Brain Dev; 2011 Mar; 33(3):243-51. PubMed ID: 21112168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed copper transport in humans. Part 1: mutations of the ATP7A gene lead to Menkes disease and occipital horn syndrome.
    Seidel J; Møller LB; Mentzel HJ; Kauf E; Vogt S; Patzer S; Wollina U; Zintl F; Horn N
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL141-8. PubMed ID: 11936860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small amounts of functional ATP7A protein permit mild phenotype.
    Møller LB
    J Trace Elem Med Biol; 2015; 31():173-7. PubMed ID: 25172213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menkes' kinky hair disease. I. Comparison of classical and unusual clinical and biochemical features in two patients.
    Willemse J; Van den Hamer CJ; Prins HW; Jonker PL
    Brain Dev; 1982; 4(2):105-14. PubMed ID: 7091567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome.
    Gu YH; Kodama H; Murata Y; Mochizuki D; Yanagawa Y; Ushijima H; Shiba T; Lee CC
    Am J Med Genet; 2001 Mar; 99(3):217-22. PubMed ID: 11241493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular localization and loss of copper responsiveness of Mnk, the murine homologue of the Menkes protein, in cells from blotchy (Mo blo) and brindled (Mo br) mouse mutants.
    La Fontaine S; Firth SD; Lockhart PJ; Brooks H; Camakaris J; Mercer JF
    Hum Mol Genet; 1999 Jun; 8(6):1069-75. PubMed ID: 10332039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targets in Menkes disease - prospective developments.
    Kodama H; Gu YH; Mizunuma M
    Expert Opin Ther Targets; 2001 Oct; 5(5):625-635. PubMed ID: 12540288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menkes disease: an X-linked neurological disorder of the copper metabolism.
    Horn N; Tønnesen T; Tümer Z
    Brain Pathol; 1992 Oct; 2(4):351-62. PubMed ID: 1341968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mRNAs for lysyl oxidase and type III procollagen in cultured fibroblasts from patients with the Menkes and occipital horn syndromes as determined by quantitative polymerase chain reaction.
    Kemppainen R; Hämäläinen ER; Kuivaniemi H; Tromp G; Pihlajaniemi T; Kivirikko KI
    Arch Biochem Biophys; 1996 Apr; 328(1):101-6. PubMed ID: 8638917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.